New AI Market Research Report
AI in Life Sciences: What the Industry Is Really Saying – The Pulse on Adoption, Opportunities, and Impact Artificial Intelligence is moving beyond experimentation and […]
New AI Market Research Report Read More »
Radar
2026 Life Sciences Radar: How to Turn Disruption into Competitive Advantage
Axendia’s 8th Annual Life Sciences Industry Radar: “A Straight from the Source Event“ Turning Disruption into Competitive Advantage Axendia unveiled its 2026 Life Sciences Radar
2026 Life Sciences Radar: How to Turn Disruption into Competitive Advantage Read More »
The Expanding Role of AI in Life Sciences: Axendia’s New AI in Life Sciences Market Research
AI is transforming Life Sciences. It is moving from generating insights to coordinating workflows and making decisions that support quality, safety, and innovation. We want
FDA CSA Just Removed Your Excuses for Implementing Modern Technology
The U.S. Food and Drug Administration has just made it official: your excuses for clinging to outdated systems because of antiquated validation practices are gone.
FDA CSA Just Removed Your Excuses for Implementing Modern Technology Read More »
Axendia at 20: Forging the Future of Life Sciences!
In 2005, Axendia was founded to meet a critical need: trusted, strategic, and actionable advice from experts who truly understand the intricate balance of business,
Axendia at 20: Forging the Future of Life Sciences! Read More »
Veeva Expands Its Vision for Quality and Manufacturing
Veeva Briefing Note Veeva’s Mike Jovanis, President, Quality Cloud, Jamie Crouch, VP Marketing, Quality Cloud, and Ashley McMillan, Senior Director, Veeva LIMS Strategy, provided an in-depth update on their continued progress
Veeva Expands Its Vision for Quality and Manufacturing Read More »
Congress Wants to Map the Pharmaceutical Supply Chain
What you need to know about the Bipartisan MAPS Act In the age of continuous disruption, from pandemics to geopolitical conflicts and trade uncertainty, the
Congress Wants to Map the Pharmaceutical Supply Chain Read More »
Driving AI Integrity in Life Sciences
EQTY Lab Briefing Note Axendia was briefed by the executive team at EQTY Lab, including Dr. Tina Dr. Morrison, VP Scientific Strategy and Alistair Dootson, Head of Life
Driving AI Integrity in Life Sciences Read More »
Why Paper Won’t Cut It In FDA’s Remote Oversight Era
FDA Expects That Records be Submitted in Electronic Format Nestled within FDA’s final guidance on Remote Regulatory Assessments (RRAs) is a pivotal and decisive statement:
Why Paper Won’t Cut It In FDA’s Remote Oversight Era Read More »
The Evolution of AI in Quality Management
From Simple Prompts to Autonomous Systems Artificial intelligence is driving a significant transformation in quality management. Quality management is evolving from basic command-based interactions into
The Evolution of AI in Quality Management Read More »
The FDA’s New Chapter
Life Sciences Strategies for Adapting Under Dr. Marty Makary’s Leadership in 2025 and Beyond! As a Sr. Industry Analyst who closely tracks the pulse of
The FDA’s New Chapter Read More »
Continuous Innovation and Improvement – The Cornerstone for Resilience
Axendia’s 7th Annual Life Sciences Industry Radar – “Straight from the Source (SftS) Event“ Axendia unveiled its 7th annual Life Sciences Industry Radar in the
Continuous Innovation and Improvement – The Cornerstone for Resilience Read More »